Philip K. Yachmetz, EVP, Chief Business Officer at SAVIENT PHARMACEUTICALS INC (SVNT), sold 3,051 shares at $14.44 ($44K) on 2007-02-15, disclosed to the SEC on 2007-02-20.
Scheduled sale ($44k) by EVP, Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| SVNT | SELL | 2013-01-16 | $1K | — | Filing → |
| SVNT | SELL | 2012-02-23 | $7K | — | Filing → |
| SVNT | BUY | 2011-09-16 | $29K | — | Filing → |